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Aureobasidium pullulans is a saprophytic dematiaceous fun-
gus with melanin-pigmented cell wall.1 It is the best known
Aureobasidium species for causing emerging human diseases
including peritonitis in patients on peritoneal dialysis, splenic
abscess, meningitis, skin and soft tissue infections, as well as
septicemia in patients with malignancies or receiving major
surgery.2 Catheter-related septicemia has rarely been
reported.2—5 We report herein one probable case and the
other a confirmed case of catheter-related A. pullulans
septicemia. The isolates were confirmed by molecular meth-
odology, and cases of A. pullulans septicemia were reviewed.
A 61-year-old woman was admitted for sudden onset of
loss of consciousness two years after the diagnosis and
surgical resection of hepatocellular carcinoma. Her Glasgow
coma score was E1M4V1 at admission. A computed tomogra-
phy of the head was emergently performed and disclosed a
large hemorrhagic area measuring 73 mm at the left frontal
lobe. Hematoma evacuation was performed immediately and
revealed a tumor measuring 3  3  3 cm located superfi-
cially in the left frontal area, and pathology demonstrated
metastatic carcinoma. A central venous catheter (CVC) was
placed in the right femoral vein for vascular access on the 1st
hospital day. Methylprednisolone 40 mg every 6 hours was
given for cerebral edema and tapered off after 11 days of use.
A spiking fever of up to 39 8C developed on the 26th
hospital day. Physical examination was unremarkable except
for local redness over the CVC insertion site. The catheter
was removed after 26 days of use due to suspicion of CVC-
related infection. The catheter tip culture yielded a yeast-
like organism and the colony turned black after prolonged
incubation. Culture of blood from the CVC in a BACTEC
9240 Myco/F Lytic bottle (Becton Dickinson, Sparks, MD,
USA) yielded a yeast-like organism after 48-hours of incuba-
tion. The colony was mucoid, and microscopic exam revealed
hyaline yeast-like cells mixed with black yeast-like cells. The
initial identification using VITEC identification system (Yeast
Biochemical Card, bioMerieux, France) revealed 90% similar-
ity with Cryptococcus laurentii. However, after 7 days of
incubation on inhibitory mold agar (IMA, BBL Microbiology
Systems, Cockeysville, MD, USA) the colony became brown to
black (Figure 1A). Slide culture using cornmeal agar (BBL
Microbiology Systems) incubated at 25 8C revealed typical
morphology of A. pullulans; thick-walled pigmented arthro-1201-9712/$32.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.02.004conidia with oval-shaped oval blastic conidia (Figure 1B).1
The fever resolved after removal of the CVC and thus no
antifungal agent was given. A follow-up blood culture after
the catheter removal was sterile. She was transferred to
another hospital on the 33rd day of hospitalization in stable
condition with improved neurological status.
A 54-year-old woman was admitted for removal of a left
back pleural-cutaneous fistula with left-side empyema. She
had suffered esophageal rupture with surgical repair 5 years
prior to this admission. Another episode of empyema com-
plicated with pleural-cutaneous fistula had been corrected
by surgery 10 months before this admission, but the surgical
wound remained poorly healed. After admission, empirical
treatment for her empyema was given with intravenous
ampicillin/sulbactam 3 g every 6 hours and gentamicin
80 mg every 12 hours. The wound culture revealed viridans
streptococci three days later. Panendoscopy on the 7th hos-
pital day disclosed an esophageal fistula, which was removed
on the 10th hospital day. Total parenteral nutrition was given
after the surgery via a right femoral CVC and was reinserted
over the right internal jugular vein on the 28th hospital day.
Intravenous ticarcillin/clavulanate 3.1 g every 6 hours, ami-
kacin 200 mg every 12 hours, and fluconazole 200 mg every
day were started on the 32nd hospital day for Stenotropho-
monas maltophilia pneumonia and Candida glabrata
empyema. The fever gradually subsidedwith antibiotic treat-
ment five days later.
On the 45th hospital day, her condition worsened with new
fever and chills and a body temperature of 39 8C. The phy-
sical examination was unremarkable except for a tender
lymph node measuring 1  2 cm near the CVC insertion site.
The right internal jugular CVC was removed after 18 days of
use and the CVC tip was sent for culture. Laboratory data
revealed a leukocyte count of 6.58  109/l with segmented
neutrophils 81.3%. One of the two blood fungal culture sets
from peripheral blood revealed a yeast-like organism and the
colony turned black after 7 days. The colony later turned
black and A. pullulans was identified. The CVC tip culture
also yielded a mucoid colony that was also identified as A.
pullulans. Amphotericin B 0.5 mg/kg/day was given for
breakthrough fungal infection under fluconazole and contin-
ued for 7 days. Oral fluconazole 100 mg/day was used as
maintenance for another 56 days. The swollen lymph node
resolved with the antifungal treatment. A follow-up blood
culture one month later was sterile. The patient was dis-
charged in stable condition on the 82nd hospital day.Published by Elsevier Ltd. All rights reserved.
Figure 1 (A) Colonic morphology of the isolate recovered from
the central venous catheter tip of patient 2, which grew on
inhibitory mold agar (IMA) for 3 days (left) and that of the isolate
from the blood culture, which grew on IMA for 7 days (right). (B)
Microscopic examination revealed yeast-like cells (magnification
1000).
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e138 CorrespondenceThe nucleotide sequences of the internal transcribed
spacer (ITS) regions of rRNA genes (including ITS1, the 5.8S
rRNA gene, and ITS2) of the two isolates were examined using
two sets of primers as previously described.6 The sequences
obtained were analyzed using GCG software (Wisconsin pack-
age; version 10.1 for Unix) and the BLASTN program (National
Center for Biotechnology Information Internet homepage).
Both sequences showed 100% (544/544) identity to A. pull-
ulans (accession number DQ680686).
Diagnosis of A. pullulans by molecular methods for con-
firmation may be necessary because conventional identifica-
tion systems may be erroneous as previously reported and in
our first case.7 Analyzing the variable sequence area within
Correspondence e139fungal ribosomal RNA genes (ITS1 and ITS2) has been noted to
play an important role in characterization and identification
of fungi.8 The clinical findings of A. pullulans septicemia from
the literature and the two cases in the present report are
summarized in Table 1. These reported cases comprised
patients with underlying malignancies as well as in surgical
patients with prolonged intravascular catheter usage.
Treatment for A. pullulans is not standardized because of
its rarity. Amphotericin B and fluconazole have been used for
the treatment of A. pullulans septicemia2,3 (Table 1). Cathe-
ter removal should perhaps be mandatory as in our first
patient, who did not receive any antifungal agents and
recovered solely after catheter removal. The need for cathe-
ter removal has also been emphasized in peritoneal dialysis-
related peritonitis caused by A. pullulans.2 A similar experi-
ence has also been reported in catheter-related Aspergillus
fungemia.4
These two cases have several implications: first, although
encountered rarely, A. pullulans can cause CVC-related sep-
ticemia and catheter removal may be necessary. Second,
physicians and laboratorians should raise their suspicion of A.
pullulans when an atypical mucoid yeast isolate is found,
especially if the colonies turn black after prolonged incuba-
tion and a commercial identification system misidentifies
these as Cryptococcus species.
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